• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与运动障碍易感性相关的 NMDA 受体基因型。

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia.

机构信息

Mental Health Research Institute, Tomsk, Russia.

出版信息

Transl Psychiatry. 2012 Jan 10;2(1):e67. doi: 10.1038/tp.2011.66.

DOI:10.1038/tp.2011.66
PMID:22832729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3309543/
Abstract

Dyskinesias are involuntary muscle movements that occur spontaneously in Huntington's disease (HD) and after long-term treatments for Parkinson's disease (levodopa-induced dyskinesia; LID) or for schizophrenia (tardive dyskinesia, TD). Previous studies suggested that dyskinesias in these three conditions originate from different neuronal pathways that converge on overstimulation of the motor cortex. We hypothesized that the same variants of the N-methyl-D-aspartate receptor gene that were previously associated with the age of dyskinesia onset in HD were also associated with the vulnerability for TD and not LID. Genotyping patients with LID and TD revealed, however, that these two variants were dose-dependently associated with susceptibility to LID, but not TD. This suggested that LID, TD and HD might arise from the same neuronal pathways, but TD results from a different mechanism.

摘要

运动障碍是亨廷顿病(HD)中自发性出现的不随意肌肉运动,也是长期治疗帕金森病(左旋多巴诱导的运动障碍;LID)或精神分裂症(迟发性运动障碍,TD)后的结果。先前的研究表明,这三种病症中的运动障碍源于不同的神经元通路,这些通路汇聚在对运动皮层的过度刺激上。我们假设,先前与 HD 中运动障碍发病年龄相关的相同 N-甲基-D-天冬氨酸受体基因变异也与 TD 易感性相关,而与 LID 无关。然而,对 LID 和 TD 患者进行基因分型的结果表明,这两种变异与 LID 的易感性呈剂量依赖性相关,但与 TD 无关。这表明 LID、TD 和 HD 可能源于相同的神经元通路,但 TD 是由不同的机制引起的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f582/3309543/adc33fa7ca3d/tp201166f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f582/3309543/adc33fa7ca3d/tp201166f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f582/3309543/adc33fa7ca3d/tp201166f1.jpg

相似文献

1
NMDA receptor genotypes associated with the vulnerability to develop dyskinesia.与运动障碍易感性相关的 NMDA 受体基因型。
Transl Psychiatry. 2012 Jan 10;2(1):e67. doi: 10.1038/tp.2011.66.
2
Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.精神分裂症中N-甲基-D-天冬氨酸(NMDA)受体亚基2B(GRIN2B)基因多态性与迟发性运动障碍的关联分析。
Psychiatry Res. 2007 Dec 3;153(3):271-5. doi: 10.1016/j.psychres.2006.08.007. Epub 2007 Jul 31.
3
Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.帕金森病双相和峰剂量运动障碍的差异遗传易感性。
Mov Disord. 2011 Jan;26(1):73-9. doi: 10.1002/mds.23400. Epub 2010 Oct 13.
4
Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.帕金森病异动症和亨廷顿舞蹈症中全身不自主运动的幅度和运动地形图的短期变异性。
Clin Neurol Neurosurg. 2008 Feb;110(2):160-7. doi: 10.1016/j.clineuro.2007.10.010. Epub 2007 Dec 3.
5
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.迟发性运动障碍和左旋多巴诱导的运动障碍是否有共同的遗传风险因素?一项探索性研究。
J Mol Neurosci. 2013 Oct;51(2):380-8. doi: 10.1007/s12031-013-0020-x. Epub 2013 May 12.
6
Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.精神分裂症中RGS9基因的遗传变异与抗精神病药物所致迟发性运动障碍的分析
Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):239-42. doi: 10.1002/ajmg.b.30796.
7
DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.帕金森病中 DAT 基因多态性(rs28363170,rs393795)与左旋多巴诱导的异动症
Neurosci Lett. 2019 Jan 18;690:83-88. doi: 10.1016/j.neulet.2018.10.021. Epub 2018 Oct 11.
8
A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea.一项关于亨廷顿舞蹈症、迟发性运动障碍和左旋多巴诱发的舞蹈症中不自主运动抑制性的双盲研究。
Clin Neuropharmacol. 1990 Jun;13(3):236-40. doi: 10.1097/00002826-199006000-00006.
9
Force overflow and levodopa-induced dyskinesias in Parkinson's disease.帕金森病中的强迫性溢出和左旋多巴诱发的异动症。
Brain. 2002 Apr;125(Pt 4):871-9. doi: 10.1093/brain/awf084.
10
Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.分析多巴胺 D1 受体(DRD1)基因的遗传变异与精神分裂症抗精神病药物所致迟发性运动障碍的关系。
Eur J Clin Pharmacol. 2011 Apr;67(4):383-388. doi: 10.1007/s00228-010-0967-2. Epub 2010 Dec 22.

引用本文的文献

1
CHRM2 and GRIN2A polymorphisms in tardive dyskinesia and cognitive impairments in Chinese Han schizophrenia.中国汉族精神分裂症患者迟发性运动障碍和认知障碍中的CHRM2和GRIN2A基因多态性
J Neural Transm (Vienna). 2025 May 30. doi: 10.1007/s00702-025-02954-8.
2
Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis.苯甲酸钠对神经精神疾病认知功能的影响:一项系统评价与荟萃分析
Front Psychiatry. 2024 Sep 9;15:1370431. doi: 10.3389/fpsyt.2024.1370431. eCollection 2024.
3
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.

本文引用的文献

1
Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.帕金森病双相和峰剂量运动障碍的差异遗传易感性。
Mov Disord. 2011 Jan;26(1):73-9. doi: 10.1002/mds.23400. Epub 2010 Oct 13.
2
Huntington's disease.亨廷顿舞蹈症
BMJ. 2010 Jun 30;340:c3109. doi: 10.1136/bmj.c3109.
3
Molecular mechanisms of pathogenesis of Parkinson's disease.帕金森病发病机制的分子机制。
多巴胺通路和帕金森病风险变异与左旋多巴诱导的运动障碍有关。
Mov Disord. 2024 Oct;39(10):1773-1783. doi: 10.1002/mds.29960. Epub 2024 Aug 12.
4
Levodopa-Induced Dyskinesias in Parkinson's Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions.帕金森病中的左旋多巴诱发异动症:病理生理学、临床表现、治疗管理策略及未来方向概述
J Clin Med. 2023 Jun 30;12(13):4427. doi: 10.3390/jcm12134427.
5
The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.DRD2 多态性与精神分裂症患者代谢综合征的性别特异性关联。
Genes (Basel). 2022 Jul 23;13(8):1312. doi: 10.3390/genes13081312.
6
Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia.精神分裂症患者谷氨酸能系统基因与迟发性运动障碍
Diagnostics (Basel). 2022 Jun 22;12(7):1521. doi: 10.3390/diagnostics12071521.
7
Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.与迟发性运动障碍相关的遗传因素:从临床前模型到临床研究
Front Pharmacol. 2022 Jan 24;12:834129. doi: 10.3389/fphar.2021.834129. eCollection 2021.
8
Study of Early Onset Schizophrenia: Associations of and Polymorphisms.早发性精神分裂症的研究:[基因名称1]和[基因名称2]多态性的关联
Life (Basel). 2021 Sep 22;11(10):997. doi: 10.3390/life11100997.
9
Current Knowledge on the Background, Pathophysiology and Treatment of Levodopa-Induced Dyskinesia-Literature Review.左旋多巴诱发异动症的背景、病理生理学及治疗的当前知识——文献综述
J Clin Med. 2021 Sep 25;10(19):4377. doi: 10.3390/jcm10194377.
10
Genome wide study of tardive dyskinesia in schizophrenia.精神分裂症迟发性运动障碍的全基因组研究。
Transl Psychiatry. 2021 Jun 8;11(1):351. doi: 10.1038/s41398-021-01471-y.
Int Rev Cell Mol Biol. 2010;281:229-66. doi: 10.1016/S1937-6448(10)81006-8.
4
Huntington's disease: pathogenesis to animal models.亨廷顿病:从发病机制到动物模型。
Pharmacol Rep. 2010 Jan-Feb;62(1):1-14. doi: 10.1016/s1734-1140(10)70238-3.
5
Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.谷氨酸、GABA 及相关基因在精神分裂症和双相情感障碍中的遗传关联研究:十年进展。
Neurosci Biobehav Rev. 2010 May;34(6):958-77. doi: 10.1016/j.neubiorev.2010.01.002. Epub 2010 Jan 7.
6
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.抗精神病药剂量当量和剂量年:一种比较不同药物暴露的标准化方法。
Biol Psychiatry. 2010 Feb 1;67(3):255-62. doi: 10.1016/j.biopsych.2009.08.040. Epub 2009 Nov 7.
7
SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies.SNPinfo:将全基因组关联研究(GWAS)和候选基因信息整合到用于基因关联研究的功能性单核苷酸多态性(SNP)选择中。
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W600-5. doi: 10.1093/nar/gkp290. Epub 2009 May 5.
8
Excitotoxic neuronal death and the pathogenesis of Huntington's disease.兴奋性毒性神经元死亡与亨廷顿舞蹈病的发病机制
Arch Med Res. 2008 Apr;39(3):265-76. doi: 10.1016/j.arcmed.2007.11.011.
9
Measuring movement disorders in antipsychotic drug trials: the need to define a new standard.
J Clin Psychopharmacol. 2007 Oct;27(5):423-30. doi: 10.1097/jcp.0b013e31814f1105.
10
Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.精神分裂症中N-甲基-D-天冬氨酸(NMDA)受体亚基2B(GRIN2B)基因多态性与迟发性运动障碍的关联分析。
Psychiatry Res. 2007 Dec 3;153(3):271-5. doi: 10.1016/j.psychres.2006.08.007. Epub 2007 Jul 31.